Publications by authors named "Houxiang Ya"

Claim this Profile
W
Whether Adjuvant TACE Plus TKI Therapy is More Effective Than TACE Alone in HCC Patients at High Risks of Recurrence Following Radical Hepatectomy.
Yaohua Li, Kai Wang, Huixia Qin, Shengjun Huo, Kaiwen Jiang, Houxiang Ya, Liya Suo

J Hepatocell Carcinoma· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety Analysis of Transarterial Chemoembolization Combined with Sintilimab Plus Bevacizumab Biosimilar in the Treatment of Unresectable Hepatocellular Carcinoma.
Huixia Qin, Kaiwen Jiang, Chengyuan Liu, Hesheng Lin, Jing Xia, Houxiang Ya, Liya Suo

J Hepatocell Carcinoma· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Lenvatinib Plus Programmed Death-1 Inhibitors with or Without Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma.
Ming Jin, Zhi-Qing Jiang, Jia-Hui Qin, Hui-Xia Qin, Kai-Wen Jiang, Hou-Xiang Ya, Yao-Hua Li

J Hepatocell Carcinoma· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Complete response after transcatheter arterial chemoembolization combined with donafenib plus tislelizumab therapy for hepatocellular carcinoma with main trunk portal vein tumor thrombus in a patient coinfected with HIV and HBV.
Xuhua Xiao, Haixiao Fu, Huixia Qin, Longkuan Xu, Jing Gu, Houxiang Ya

Front Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nomogram for predicting severe abdominal pain after initial conventional transarterial chemoembolisation for hepatocellular carcinoma: a retrospective study.
Huixia Qin, Xuhua Xiao, Houxiang Ya, Jinhai Li, Fugang Liang, Yaohua Li

Sci Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis